AGP Limited Secures 1st Position at BCSR Awards 2023

AGP collaborates with Childlife Foundation on Children’s Day 2023

AGP Launched Peridots – A Thanda Solution to Acidity, Gas and Indigestion

AGP secures 2nd Position at BCR Awards 2022

AGP wins Top Exporter Award at 6th PPMA Summit

AGP sponsors KDSP Carnival 2023

AGP bags big win at GDEIB Awards 2023

AGP continues partnership with IBA

AGP continues collaboration with TCF

AGP joins hands with SKMF

AGP continues partnership with ACF

AGP conducts Allergy Awareness Session At Pak Turk Maarif

Gong-Ringing Ceremony of AGP at PSX

Home > Products > MyHep All

Product List

MyHep All

Generic:

Sofosbuvir, Velpatasvir

 

Therapeutic Class:

Hepatitis C Antivirals

 

Composition:

Each MyHep All tablet contains Sofosbuvir 400 mg and Velpatasvir 100 mg.

 

Description:

MyHep All is a fixed-dose combination tablet containing sofosbuvir and velpatasvir for oral administration. Sofosbuvir is a nucleotide analog HCV NS5B polymerase inhibitor and velpatasvir is an NS5A inhibitor.

 

Indications:

MyHep All is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) infection.

Dosage:

The recommended dosage of MyHep All is one tablet taken orally once daily with or without food.

 

Presentation:

  • MyHep All Tab is available in a pack of 28’s.